Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's”

3,151 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,151 results

Not applicableUnknownNCT04012346
What this trial is testing

Modulation of Cognition and Brain Connectivity by Noninvasive Brain Stimulation in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment
Masaryk University 20
Testing effectiveness (Phase 2)Study completedNCT01782742
What this trial is testing

Bexarotene Amyloid Treatment for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
The Cleveland Clinic 20
Not applicableStudy completedNCT01188070
What this trial is testing

Caregiver Stress: Interventions to Promote Health and Wellbeing

Who this might be right for
Health Promotion
Emory University 354
Not applicableStudy completedNCT04300569
What this trial is testing

Determine the Signs and Symptoms That Impact Daily Life of Participants With Irregular Sleep-Wake Rhythm Disorder

Who this might be right for
Irregular Sleep Wake Rhythm Disorder
Eisai Inc. 37
Not applicableStudy completedNCT04968041
What this trial is testing

KNA Proof-of-Concept

Who this might be right for
Adherence, TreatmentRetentionCognitive Impairment, Mild
Florida State University 10
Not applicableStudy completedNCT03405662
What this trial is testing

Impact of Photobiomodulation (PBM) on Biomarkers of Alzheimer's Disease

Who this might be right for
Alzheimer Disease
University of California, San Francisco 23
Early research (Phase 1)Study completedNCT02187627
What this trial is testing

Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) Participants

Who this might be right for
Alzheimer's Disease, Healthy Volunteer
Hoffmann-La Roche 52
Testing effectiveness (Phase 2)Study completedNCT05979922
What this trial is testing

Mindfulness-based Cognitive Coping for ADRD Caregivers

Who this might be right for
Caregiver Stress
Photozig, Inc. 174
Not applicableLooking for participantsNCT06965062
What this trial is testing

Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)

Who this might be right for
Alzheimer DiseaseDementia Alzheimer TypeDementia Alzheimer's Type+2 more
Vincent Tay Khwee Soon 10
Not applicableStudy completedNCT02198586
What this trial is testing

Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years Old

Who this might be right for
Alzheimer's Disease
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation 575
Testing effectiveness (Phase 2)Study completedNCT04388254
What this trial is testing

Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 220
Post-approval studies (Phase 4)Study completedNCT01585272
What this trial is testing

Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia

Who this might be right for
Alzheimer's Dementia
Novartis Pharmaceuticals 121
Not applicableStudy completedNCT03313895
What this trial is testing

The Combined Aerobic Exercise and Cognitive Training (ACT) Trial: The ACT Trial

Who this might be right for
Mild Cognitive Impairment
Arizona State University 146
Not applicableUnknownNCT06304129
What this trial is testing

Diagnostic Performance of Plasma Biomarkers of Alzheimer's Disease Compared With CSF Markers

Who this might be right for
Alzheimer Blood Biomarkers
Central Hospital, Nancy, France 189
Testing effectiveness (Phase 2)Study completedNCT05063539
What this trial is testing

LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 327
Not applicableStudy completedNCT04948866
What this trial is testing

Palliative Care for Persons With Late-stage Alzheimer's and Related Dementias and Their Caregivers

Who this might be right for
DementiaDementia, VascularDementia With Lewy Bodies+5 more
University of North Carolina, Chapel Hill 884
Early research (Phase 1)Study completedNCT05466422
What this trial is testing

MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)

Who this might be right for
Alzheimer Disease
Merck Sharp & Dohme LLC 34
Not applicableStudy completedNCT05803122
What this trial is testing

Validation of the I-UDS Neuropsychological Battery

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
IRCCS National Neurological Institute "C. Mondino" Foundation 252
Not applicableUnknownNCT00900770
What this trial is testing

Implications of Amyloid Pathology

Who this might be right for
Alzheimer's Disease
National Institute on Aging (NIA) 100
Post-approval studies (Phase 4)Study completedNCT02097056
What this trial is testing

Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Korea Inc. 171
Next Page